Evidence map›Paper›PMID 42879392›Full record

ArticlePLoS pathogens2026

HIV-1 compartmentalization in the central nervous system during cryptococcal meningitis: Analysis of viral, fungal, and host factors.

Maura Manion, Camille M Lange, Ana M Ortega-Villa, Christine M Fennessey, Brandon F Keele, Matthew Moeser, Helene Highbarger, Kristi Huik, Natalie Lindo, Christian Gonsalves and 6 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maura ManionIntramural Clinical Management and Operations Branch, Office of the Clinical Director, National Institute of Allergy and Infectious Disease (NIAID), NIH, Bethesda, Maryland, United States of America.ORCID https://orcid.org/0000-0003-0991-0011
Camille M LangeClinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.
Ana M Ortega-VillaOffice of Biostatistics Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Christine M FennesseyAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Brandon F KeeleAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Matthew MoeserDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Helene HighbargerVirus Isolation and Serology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Kristi HuikClinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.
Natalie LindoClinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.
Christian GonsalvesClinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.
James VirgaClinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.ORCID https://orcid.org/0000-0003-2539-4029
David B MeyaDepartment of Medicine, School of Medicine, College of Health Sciences Makerere University, Kampala, Uganda.
Sarah B JosephDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
David R BoulwareDepartment of Medicine and International Health, University of Minnesota, Minneapolis, Minnesota, United States of America.
Irini SeretiLaboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Disease (NIAID), NIH, Bethesda, Maryland, United States of America.
Frank MaldarelliClinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opportunistic infections in the central nervous system (CNS), such as cryptococcal meningitis (CM) have profound consequences for people living with HIV-1 (PWH), including blood-brain barrier impairment and neuroinflammation. To investigate how CM may shape the HIV-1 populations in the CNS, we characterized viral variants in the blood and cerebrospinal fluid (CSF) compartments in PWH with active CM. Thirty-nine participants with CM had paired plasma and CSF viral load measurements prior to the start of anti-retroviral therapy (pre-ART), with overall significantly higher HIV-1 viral loads in plasma compared to the CSF. Among those with CSF pleocytosis, CSF viral loads were relatively higher and CCR5 coreceptor-utilizing HIV-1 were more frequently detected. To investigate whether these differences were due to sustained HIV-1 replication in the CNS that generated genetically distinct viral lineages in the CSF (i.e., viral compartmentalization), we characterized pre-ART HIV-1 env populations in a subgroup of eighteen PWH with CSF HIV-1 RNA levels > blood (N = 9) and CSF RNA levels < blood (N = 9). Compartmentalization between CSF and plasma viral populations was detected in participants from both groups and was associated with higher interleukin-2 (IL-2) levels in CSF. In some cases, HIV-1 populations in CSF were compartmentalized from plasma, were exclusively macrophage-tropic and reached levels exceeding 105 copies/ml CSF. In other cases, HIV-1 infected cells trafficking across the plasma and CSF compartments seemed the most likely source of virus in the CSF. Post-ART analysis in one participant demonstrated emergence of distinct HIV-1 populations. This study demonstrates that opportunistic infections may have diverse effects in shaping HIV-1 viral populations.

Indexed as

AIDS-Related Opportunistic InfectionsCentral Nervous SystemHIV-1HIV InfectionsMeningitis, CryptococcalAdultFemaleHumansMaleMiddle AgedRNA, ViralViral LoadRNA, Viral

Identifiers

PMID42879392
PMCPMC13671554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.